Biote (BTMD) Net Cash Flow (2021 - 2026)

Biote has reported Net Cash Flow for 6 years, with the latest figure at -$18.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 896.15% year-over-year to -$18.8 million; the trailing twelve-month figure through Mar 2026 stood at -$36.4 million (up 1.81% YoY), and the FY2025 full-year result was -$15.2 million, up 69.33% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$18.8 million, down from -$3.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $55.0 million in Q2 2022, with the low at -$52.4 million in Q2 2024.
• Average Net Cash Flow over 5 years is -$1.3 million, with a median of $925000.0 recorded in 2022.
• Year-over-year, Net Cash Flow slumped 1812.05% in 2022 and surged 1228.06% in 2023.
• Tracing BTMD's Net Cash Flow over 5 years: stood at $1.8 million in 2022, then surged by 1228.06% to $23.4 million in 2023, then sank by 95.21% to $1.1 million in 2024, then sank by 449.6% to -$3.9 million in 2025, then sank by 378.99% to -$18.8 million in 2026.
• The last three Net Cash Flow figures came in at -$18.8 million (Q1 2026), -$3.9 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.

Peer Comparison